Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1952 1
1953 2
1956 2
1957 1
1962 1
1965 2
1966 1
1967 2
1971 1
1973 1
1975 1
1976 1
1977 2
1978 2
1979 4
1980 2
1981 1
1982 6
1983 8
1984 3
1985 2
1986 1
1987 6
1988 5
1989 2
1990 1
1991 6
1992 5
1993 2
1994 3
1995 2
1996 4
1997 4
1998 2
1999 3
2000 3
2001 4
2002 9
2003 6
2004 2
2005 8
2006 9
2007 8
2008 11
2009 13
2010 9
2011 15
2012 10
2013 18
2014 6
2015 27
2016 23
2017 24
2018 12
2019 29
2020 30
2021 27
2022 24
2023 35
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

430 results

Results by year

Filters applied: . Clear all
Page 1
Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition.
Pasciuto E, Burton OT, Roca CP, Lagou V, Rajan WD, Theys T, Mancuso R, Tito RY, Kouser L, Callaerts-Vegh Z, de la Fuente AG, Prezzemolo T, Mascali LG, Brajic A, Whyte CE, Yshii L, Martinez-Muriana A, Naughton M, Young A, Moudra A, Lemaitre P, Poovathingal S, Raes J, De Strooper B, Fitzgerald DC, Dooley J, Liston A. Pasciuto E, et al. Among authors: de la fuente ag. Cell. 2020 Aug 6;182(3):625-640.e24. doi: 10.1016/j.cell.2020.06.026. Epub 2020 Jul 22. Cell. 2020. PMID: 32702313 Free PMC article.
Novel therapeutic approaches to target neurodegeneration.
de la Fuente AG, Pelucchi S, Mertens J, Di Luca M, Mauceri D, Marcello E. de la Fuente AG, et al. Br J Pharmacol. 2023 Jul;180(13):1651-1673. doi: 10.1111/bph.16078. Epub 2023 Apr 26. Br J Pharmacol. 2023. PMID: 36965025 Free PMC article. Review.
Glial cell alterations in diabetes-induced neurodegeneration.
Llorián-Salvador M, Cabeza-Fernández S, Gomez-Sanchez JA, de la Fuente AG. Llorián-Salvador M, et al. Among authors: de la fuente ag. Cell Mol Life Sci. 2024 Jan 18;81(1):47. doi: 10.1007/s00018-023-05024-y. Cell Mol Life Sci. 2024. PMID: 38236305 Free PMC article. Review.
[Gastric fibroma].
De la Fuente AG, Granado JM, Lavalle JA, Ochoa P, Jaraba JI, Olmo A. De la Fuente AG, et al. Lyon Chir. 1971 Jul-Aug;67(4):305-7. Lyon Chir. 1971. PMID: 5123395 French. No abstract available.
Uterus Transplantation as a Surgical Innovation.
Pérez-Blanco A, Seoane JA, Pallás TA, Nieto-Moro M, Calonge RN, de la Fuente A, Martin DE. Pérez-Blanco A, et al. Among authors: de la fuente a. J Bioeth Inq. 2023 Sep;20(3):367-378. doi: 10.1007/s11673-023-10272-5. Epub 2023 Jun 29. J Bioeth Inq. 2023. PMID: 37382845 Free PMC article.
Autoantibodies and microglia: boon or bane?
Naughton M, de la Fuente AG. Naughton M, et al. Among authors: de la fuente ag. Brain. 2021 Sep 4;144(8):2231-2233. doi: 10.1093/brain/awab269. Brain. 2021. PMID: 34382068 No abstract available.
Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial.
Giné E, de la Cruz F, Jiménez Ubieto A, López Jimenez J, Martín García-Sancho A, Terol MJ, González Barca E, Casanova M, de la Fuente A, Marín-Niebla A, Muntañola A, González-López TJ, Aymerich M, Setoain X, Cortés-Romera M, Rotger A, Rodríguez S, Medina Herrera A, García Sanz R, Nadeu F, Beà S, Campo E, López-Guillermo A. Giné E, et al. Among authors: de la fuente a. J Clin Oncol. 2022 Apr 10;40(11):1196-1205. doi: 10.1200/JCO.21.02321. Epub 2022 Jan 14. J Clin Oncol. 2022. PMID: 35030036 Free PMC article. Clinical Trial.
430 results